Classification of deletions and identification of cryptic translocations involving 7q by fluorescence in situ hybridization (FISH). 1996

S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
MRC Molecular Haematology Unit, John Radcliffe Hospital, Oxford, UK.

Monosomy 7 (-7) and deletion of the long arm of chromosome 7, del(7q), are frequent non-random findings in the myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML), particularly associated with therapy-related disease (t-MDS and t-AML). The cytogenetic breakpoints of 7q deletions are variable, with both terminal and interstitial deletions reported. It is now believed that most deletions are interstitial, and that the variability in reported breakpoints may be due to the difficulty in determining whether the terminal, pale staining G band is present. It has also been suggested that some reported deletions of 7q may be cryptic translocations. To address these questions, we carried out fluorescence in situ hybridization (FISH) studies on leukaemic cells from a large series of patients using a chromosome 7-specific paint and a 7q telomere-specific probe. Of the 26 cases studied, seven were 'pure' deletions (ie without the involvement of other chromosomes); four were interstitial and two terminal. One further patient had two clones each with a different deletion: one with a terminal del(7)(q22) and the second with an interstitial del(7)(q32-qter). A further nine cases had unbalanced translocations with deletion of 7q terminal sequences. The remaining 10 cases were translocations and complex rearrangements, some involving interstitial deletions of 7q. In two cases in which del(7q) was reported as the sole cytogenetic abnormality by G-banding, FISH revealed cryptic translocations involving 7q.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002871 Chromosome Banding Staining of bands, or chromosome segments, allowing the precise identification of individual chromosomes or parts of chromosomes. Applications include the determination of chromosome rearrangements in malformation syndromes and cancer, the chemistry of chromosome segments, chromosome changes during evolution, and, in conjunction with cell hybridization studies, chromosome mapping. Banding, Chromosome,Bandings, Chromosome,Chromosome Bandings
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies

Related Publications

S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
October 1991, American journal of human genetics,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
January 1995, Genes, chromosomes & cancer,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
August 1993, Genes, chromosomes & cancer,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
October 2010, Current protocols in human genetics,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
June 2001, Genes, chromosomes & cancer,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
April 1994, Leukemia,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
January 1999, Genes, chromosomes & cancer,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
August 2018, Journal of microbiological methods,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
February 1997, Cancer genetics and cytogenetics,
S Tosi, and J Harbott, and O A Haas, and A Douglas, and D M Hughes, and F M Ross, and A Biondi, and S W Scherer, and L Kearney
November 1994, Blood,
Copied contents to your clipboard!